Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain

Publisher： Karger

E-ISSN： 1423-0313|92|3-4|150-157

ISSN： 0031-7012

Source： Pharmacology, Vol.92, Iss.3-4, 2013-09, pp. : 150-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoid Receptor Agonists Inhibit Ca2+ Influx to Synaptosomes from Rat Brain

By  

Pharmacology, Vol. 76, Iss. 4, 2006-04 ,pp. : 157-162

Karger

Access to resources Recommend Favorite

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2

By Yang Longhe   Li Yanting   Ren Jie   Zhu Chenggang   Fu Jin   Lin Donghai   Qiu Yan  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 13637-13648

MDPI

Access to resources Recommend Favorite

Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity

By  

Chemotherapy, Vol. 57, Iss. 4, 2011-09 ,pp. : 321-326

Karger

Access to resources Recommend Favorite

Effect of Cannabinoid Receptor Agonists on Streptozotocin-Induced Hyperalgesia in Diabetic Neuropathy

By  

Pharmacology, Vol. 82, Iss. 3, 2008-09 ,pp. : 193-200

Karger

Access to resources Recommend Favorite

Postoperative Administration of the Analgesic Tramadol, but Not the Selective Cyclooxygenase-2 Inhibitor Parecoxib, Abolishes Postoperative Hyperalgesia in a New Model of Postoperative Pain in Rats

By  

Pharmacology, Vol. 80, Iss. 4, 2007-07 ,pp. : 244-248

Karger

Access to resources Recommend Favorite